Senior Professorship Manns
Research focus
With his senior professorship, Michael Manns will concentrate primarily on the further development and scientific organisation of the CiiM and support the CiiM Directors (Markus Cornberg and Yang Li). The focus will be on
- the integration and coordination of the working groups of the MHH and the HZI as well as the core facilities and associated foundations
- the development and implementation of patient-oriented concepts of personalised infection medicine
- the acquisition of third-party funding and the establishment of sustainable national and international networks in infection and liver research
Furthermore, he will work on specific research projects together with the Clinic for Gastroenterology, Hepatology, Infectiology and Endocrinology at the MHH and the working groups there.
Research focus
With his senior professorship, Michael Manns will concentrate primarily on the further development and scientific organisation of the CiiM and support the CiiM Directors (Markus Cornberg and Yang Li). The focus will be on
- the integration and coordination of the working groups of the MHH and the HZI as well as the core facilities and associated foundations
- the development and implementation of patient-oriented concepts of personalised infection medicine
- the acquisition of third-party funding and the establishment of sustainable national and international networks in infection and liver research
Furthermore, he will work on specific research projects together with the Clinic for Gastroenterology, Hepatology, Infectiology and Endocrinology at the MHH and the working groups there.
Professor Manns is regarded as one of Europe's leading liver researchers. He has published more than 1,000 articles in international peer-reviewed journals such as The New England Journal of Medicine, The Lancet, Nature, Nature Medicine, Cell, Gastroenterology and Hepatology. For the past eight years, he has been continuously included in the list of the world's most frequently cited researchers (‘Highly Cited Researchers’) by the US company Clarivate Analytics. He has received numerous honours, including the International Hans Popper Award, the European Association for the Study of the Liver (EASL) Recognition Award and the Life Time Achievement Award of the United European Gastroenterology (UEG). He is an honorary member of numerous national and international professional societies. Professor Mann's research focuses on liver diseases with the topics viral hepatitis, autoimmune diseases of the liver, hepatocellular carcinoma, transplantation and regenerative medicine.
Since January 2025, Professor Manns has held a senior professorship at the CiiM and is associated with the Department of Gastroenterology, Hepatology, Infectiology and Endocrinology at the MHH. He studied medicine at the University of Vienna, Austria, and the University of Mainz, before continuing his clinical and scientific training at the Free University of Berlin and the University of Mainz. He specialises in internal medicine and was appointed Professor of Medicine at the University of Mainz in 1986. From 1987 to 1988, he worked as a research associate at the Scripps Clinic and Research Foundation in La Jolla, California (USA). For 29 years, he was Director of the MHH Clinic for Gastroenterology, Hepatology and Endocrinology from 1991 to 2020 and was also Clinical Director of the Helmholtz Centre for Infection Research (HZI) in Braunschweig and Founding Director of CiiM from 2015 to 2018. In 2019, Michael Manns took over responsibility for the entire MHH with the presidency, which he held until the end of 2024. His six-year term of office included the coronavirus pandemic and the associated challenges for MHH as a university hospital. However, the generational change and the upcoming new MHH building were also key topics during his time as President. His focus was on the ongoing further development of the MHH in all areas on the way to an all-encompassing Hannover Health Science Campus, particularly with regard to excellence in research.
Team
